Investing in ASX Small Caps
Investing in ASX Small Caps
Playlist by Investing in ASX Small CapsAustralia's small cap market moves fast — and the gap between informed and uninformed can be significant. Investing in ASX Small Caps delivers sharp, accessible analysis across the full breadth of ASX…6 clip(s) in playlist
Critica Limited (ASX: CRI) Webinar | Two Advanced Critical Minerals Projects. Multiple Catalysts
Critica Limited (ASX: CRI) Investor Webinar | 22 June 2026 In this webinar, Critica's CEO Jacob Deysel provides an update on the company's two critical minerals projects following significant progress across both scoping study workstreams. Mt Lindsay in Tasmania is one of the largest undeveloped t…
31:03
Advancing the Jupiter Rare Earth Project - Critica Limited (ASX: CRI)
Investability's Principal, Dannika Warburton, hosted a live webinar with Critica Ltd (ASX: CRI) CEO Jacob Deysel on Thursday, 26 February 2026. About Critica (ASX: CRI): Critica Limited is advancing the Jupiter Rare Earth Project in Western Australia — Australia’s largest clay-hosted, magnet-REE-d…
29:27
Growth Strategy, ARR & Market Opportunity - Talius Group (ASX: TAL)
Investability hosted a webinar with Talius Group (ASX: TAL) held on 2nd June 2026, Chairman Ramsay Carter, Managing Director & CEO Pat Howard, and Founder Graham Russell provide an update on the Company's strategy, recent progress and key developments. The webinar covers Talius' growing recurring …
29:08
Becoming a 80,000/oz Gold Producer - Investor Q&A with Medallion Metals (ASX: MM8)
Investability's Principal, Dannika Warburton, hosted a live webinar with Medallion Metals (ASX: MM8) Managing Director Paul Bennet on Wednesday 11th March 2026. Medallion is advancing the Ravensthorpe Gold Project (RGP) in Western Australia, located ~550km southeast of Perth at the intersection of …
25:36
Exposure to Australia's $34 Billion Pharma Market - Algorae Pharmaceuticals (ASX: 1A1)
Algorae Pharmaceuticals Ltd (ASX: 1AI) offers a dual-track, capital-efficient pathway to pharmaceutical commercialisation. The primary business is the commercial division, AlgoraeRx, which sources and supplies generic and specialty medicines to Australia and New Zealand through executed supply and …
26:57
Critica Ltd Produced High Grade MIxed Rare Earth Product from the Jupiter Project in Australian
On 28 October 2025, Investability's Principal, Dannika Warburton, hosted a live webinar with Critica Ltd (ASX: CRI) CEO Jacob Deysel. Jacob outlined the milestone first Mixed Rare Earth Product (MREP) from the Jupiter Project (84% TREO at 78% recovery), the beneficiation-first flowsheet delivering…
28:50